Bought Out

← Ledger

File 03 · Pets · 2013–2026

Veterinary care

People will pay an astonishing amount to stop a dog from suffering. Financial buyers noticed. Over a decade, independent vet clinics were rolled up by Mars, by JAB’s National Veterinary Associates, and by a swarm of smaller private-equity platforms. Most of the doors still say a neighborhood name. Estimates of how far the roll-up has gone differ by source and by what is counted — primary care versus emergency and specialty — but they agree on the direction. Prices rose far faster than general inflation. Veterinarians describe pressure to produce revenue. Owners describe invoices they could not have imagined at the same clinic ten years earlier.

+60%

veterinary prices over a decade

Active in

Corporations owned about 10% of vet practices a decade ago. More Perfect Union now puts the share near half of clinics and as high as three-quarters of emergency hospitals. The New York Times, citing Brakke Consulting, put corporate ownership nearer a quarter of primary care and three-quarters of specialty.

More Perfect Union, 2025; The New York Times, 2024

Findings

The bill
+60%

The New York Times, citing federal statistics, reported in 2024 that veterinary prices had risen more than 60% over the previous decade. More Perfect Union describes that climb as roughly double the rate of inflation.

Who owns the door
10% → ~30–50%

A decade ago, corporate owners held about a tenth of clinics. Current estimates range from roughly 30% to 50% overall, and around 75% of emergency and specialty hospitals. Primary-care estimates from Brakke are lower than some advocacy counts. Both describe a transformed market.

The biggest check
$9.1 billion

Mars, the private company behind candy and Pedigree, bought VCA in 2017 for $9.1 billion. With Banfield and BluePearl it controls more than 2,000 veterinary facilities. JAB owns NVA, the largest classic private-equity-style chain, with well over a thousand hospitals, mostly under local brands.

The playbook, in this industry

  1. 01

    Buy the doctor’s book of clients

    A clinic’s value is the neighborhood’s pets and the trust attached to a name. Deals peaked around 2021 — the Times cited PitchBook’s count of more than 200 private-equity transactions that year. Offers reached numbers solo owners said they could not morally wave off, and some did anyway.

  2. 02

    Keep the sign

    Rebranding would warn customers. NVA and other platforms typically leave the local name up. The owner is visible on a state filing, not on the door. Sites like PrivateEquityVet.org exist because the information is otherwise buried.

  3. 03

    Pay on production

    Veterinarians told the Times that corporate managers pushed clinics to run as profit centers, with compensation tied to revenue. That is a nudge toward more tests, more procedures, and more wellness plans. Some vets say the medicine did not change. The incentive is not subtle.

  4. 04

    Own the moment of panic

    Emergency and specialty hospitals are where price discipline dies. A seizure at 1 a.m. is not a market with three quotes. Corporate ownership is highest exactly there.

Incidents

  1. 2015–17

    Mars stacks the platforms

    Mars buys BluePearl, then VCA for $9.1 billion. Banfield clinics inside PetSmart were already Mars. Pet food, pet retail, and pet medicine sit in one private company.

  2. 2019–21

    The small-clinic gold rush

    General-practice roll-ups accelerate. JAB takes NVA. Independent owners report unsolicited bids as a routine part of the week. The FTC later treats some of these overlaps as competition cases, not as charming small business.

  3. 2022

    The FTC makes JAB sell clinics

    To clear acquisitions, JAB has to divest clinics in cities where the overlap would have been too tight — a rare official statement that vet care can be cornered neighborhood by neighborhood.

  4. 2024–26

    The price becomes the story

    The Times, PBS NewsHour, Senate letters from Warren and Blumenthal, and More Perfect Union’s 2025 film all describe the same household experience: a ‘local’ clinic, a corporate owner, and a bill that took the decision out of the exam room and put it in the parking lot.

Case files

Banfield, VCA, BluePearl — thousands of sites

Mars, from the candy company to the crash cart

Most people who use a Banfield inside a PetSmart do not know they are in a clinic owned by the Mars family. VCA hospitals and BluePearl referral centers extend that ownership into surgery and emergency care. This is not a classic ten-year private-equity flip. It is a permanent conglomerate using the same roll-up mechanics: buy independents, centralize purchasing and protocols, integrate food and diagnostics, and meet the customer at the most emotional purchase in the household budget. The public argument for it is capital, night staffing, and equipment a solo clinic cannot finance. The public experience of it, documented by reporters and by vets who left, is production pressure and prices that jumped in a single decade.

The public bill. Routine care that drifted out of reach, and emergency estimates in the thousands before a diagnosis is firm.

Local names, one Luxembourg holding company

NVA and the invisible local monopoly

National Veterinary Associates, owned by JAB, is the cleanest private-equity version. The hospitals are not renamed as a single chain, which is why a pet owner can ‘choose’ three clinics and hit the same owner twice. When JAB’s buying spree threatened head-to-head competition in specific cities, the FTC required divestitures rather than treat vet medicine as too small to matter. A U.K. competition investigation, cited by PBS, estimated that corporate ownership added more than a billion dollars to consumer costs over five years — not a U.S. figure, but the same mechanism under a regulator willing to count it. American pet owners are still waiting for that census.

The public bill. Choice that is partly fictional, and a decade in which vet inflation lapped the rest of the economy.

What the public lost

Cost

  • Veterinary CPI up more than 60% in a decade
  • Emergency and specialty invoices that now rival human deductibles, without the insurance most families actually have
  • Upsold diagnostics and wellness plans, encouraged by pay formulas tied to clinic revenue

Access

  • Independent clinics disappearing as retirement exits become PE exits
  • Emergency hospitals concentrated in corporate hands — the care you need at the worst hour
  • Owners declining recommended care, or surrendering animals, because the price and the bond are in conflict

The owners’ argument

Corporate owners say consolidation funded modern equipment, relief staffing, and a standard of care cottage clinics could not sustain, and that price increases track medical capability, pet humanization, and a veterinarian shortage. Those forces are real — a new ultrasound is not a conspiracy. They do not require secret ownership, revenue-based pay, or buying every clinic on a corridor. Where local competition dies, the shortage explanation and the market-power explanation can both be true. Households feel only the invoice.

Sources

Continue